Infinity Pharmaceuticals | INFI - Ebitda





Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Eisai JPY 30.1B 6.62B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Incyte USD 414.5M 92.42M 2025-12
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
J&J USD 9.52B 389M 2025-09
Novartis USD 5.88B 290M 2025-09
Pfizer USD 6.08B 351M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
TG Therapeutics USD 32.69M 5M 2025-09